BNP Paribas Financial Markets raised its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 14.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 64,498 shares of the medical technology company's stock after purchasing an additional 7,907 shares during the quarter. BNP Paribas Financial Markets owned 0.14% of Teleflex worth $15,952,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cromwell Holdings LLC raised its position in Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock valued at $33,000 after purchasing an additional 49 shares during the period. Avior Wealth Management LLC increased its position in shares of Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock worth $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC purchased a new stake in shares of Teleflex during the third quarter worth $40,000. Canada Pension Plan Investment Board purchased a new stake in shares of Teleflex during the second quarter worth $42,000. Finally, GAMMA Investing LLC increased its position in shares of Teleflex by 131.1% during the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company's stock worth $42,000 after acquiring an additional 97 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently weighed in on TFX shares. Truist Financial reaffirmed a "hold" rating and set a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Monday, November 4th. StockNews.com raised Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research report on Friday, November 1st. Mizuho cut their price objective on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, November 1st. Finally, Royal Bank of Canada dropped their target price on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $259.25.
Check Out Our Latest Analysis on Teleflex
Teleflex Stock Performance
NYSE TFX traded up $0.85 during trading hours on Friday, hitting $192.85. The company had a trading volume of 400,527 shares, compared to its average volume of 513,850. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 1-year low of $185.66 and a 1-year high of $257.85. The company has a market cap of $8.96 billion, a PE ratio of 38.34, a price-to-earnings-growth ratio of 1.97 and a beta of 1.18. The business has a 50 day moving average of $219.90 and a 200-day moving average of $222.41.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same quarter in the prior year, the firm posted $3.64 earnings per share. Teleflex's revenue for the quarter was up 2.4% on a year-over-year basis. As a group, equities research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a $0.34 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.71%. Teleflex's dividend payout ratio is presently 27.04%.
Teleflex Profile
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.